• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Bajaj Finserv Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
532978
INE918I01026
63.6130397
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAJAJFINSV
197.11
282361.03
EPS(TTM)
Face Value()
Div & Yield %
8.95
1
0.08
 

sharanam infraproject & trading ltd
Parmax Pharma reports standalone net loss of Rs 0.58 crore in the March 2026 quarter
Jun 04,2026
Net Loss of Parmax Pharma reported to Rs 0.58 crore in the quarter ended March 2026 as against net loss of Rs 1.49 crore during the previous quarter ended March 2025. Sales declined 31.47% to Rs 3.31 crore in the quarter ended March 2026 as against Rs 4.83 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 4.16 crore in the year ended March 2026 as against net loss of Rs 2.09 crore during the previous year ended March 2025. Sales declined 57.06% to Rs 12.11 crore in the year ended March 2026 as against Rs 28.20 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.314.83 -31 12.1128.20 -57
OPM %-46.83-11.59 --30.140.92 -
PBDT-2.02-0.90 -124 -4.84-0.29 -1569
PBT-2.27-0.72 -215 -5.85-1.32 -343
NP-0.58-1.49 61 -4.16-2.09 -99